Fifteen lepromatous leprosy (LL) patients undergoing erythema nodosum leprosum (ENL) reactions were compared with 13 stable, uncomplicated, anergic individuals of the same leprosy background. ENL patients showed significant antigen-induced leukocyte migration inhibition (migration index = 0.058 + 0.01), paralleling the values obtained with a responder tuberculoid leprosy population (migration index = 0.04 ± 0.004). Both phytohemagglutinin-induced general T-cell proliferation and, more significantly, antigen-induced lymphoproliferation were enhanced during the acute phase of the reaction. Suppressor cell activity, monitored by a costimulant assay, showed enhanced antigen-stimulated suppression of mitogen responses. Interestingly, the improvement in in vitro T-celi responses was not reflected in dermal reactivity, since 48-h delayed-type hypersensitivity responses after intradermal injection of soluble Mycobacterium leprae antigens continued to be poor. After subsidence of reactional lesions, leukocyte migration inhibition, lymphoproliferation, and suppressor cell activity were reduced to the unresponsive state seen in stable LL patients. Significantly, perturbations of T-cell reactivity are detectable in ENL reactions, indicating the natural but transient emergence of antigen-induced T cells in LL.
Mycobacterium leprae infection, exhibits selective, antigenspecific T-cell unresponsiveness. LL patients have poor delayed-hypersensitivity reactions and reduced lymphoproliferation in response to T-cell mitogens (3, 12) and M. leprae antigens (7, 18) . The nonspecific unresponsiveness noted in some LL patients is reversed after chemotherapy, though specific antigen-related anergy is persistent and long lasting (12, 19) . Enhanced B-cell functions have been reported in LL (18) . Immunoregulatory abnormalities due to enhanced (11) or decreased (20, 22, 23, 32, 34) suppressor T-cell activity and macrophage- (30) or monocyte-derived (31) factors have been implicated in pathogenic mechanisms underlying the defect in LL.
LL patients suffer from acute, episodic, exacerbated reactional states called erythema nodosum leprosum (ENL), which are characterized by crops of tender, erythematous, subcutaneous nodules and systemic manufestations of pyrexia, malaise, neuritis, arthralgia, and proteinuria. The mechanisms underlying ENL have been attributed to immune complex-mediated injury as evidenced by histopathology (37) , presence of immunoglobulin and complement in lesions (36) , and circulating immune complexes (1, 5, 14) and complement-degradative products (1, 6) .
In recent years, sporadic evidence of altered T-cell reactivity in patients with ENL has been observed by us (22) as well as others (27) . The present study was undertaken in LL patients to systematically evaluate the status of T-cellmediated functions during and after ENL reactions. Definitive evidence for transient improvement in T-cell functions was obtained in many LL patients during the acute phase of ENL. Significantly, antigen-induced (i) leukocyte migration inhibition, (ii) lymphoproliferation, and (iii) suppressor Tcell activity were enhanced, indicating the presence or emergence of antigen-reactive T cells in LL patients. After subsidence of ENL lesions, most patients showed a return to hyporeactivity or anergy associated universally with LL.
* Corresponding author.
Interestingly, the transient improvement in in vitro T-cell functions was not associated with the appearance of skin reactivity to concomitant intradermal injection of soluble M. leprae antigens.
MATERIALS AND METHODS Patients. Twenty-eight patients classified by the Ridley and Jopling (29) scale were included in the study. Thirteen patients had uncomplicated LL, whereas 15 presented with erythematous, subcutaneous, tender crops of nodules on an LL background and were taken as ENL patients. The clinical details are given in Table 1. Immunological studies were performed (i) during active ENL, before initiation of antireaction therapy, as well as (ii) 1 week to 4 months after stopping treatment, when clinical signs and symptoms of ENL had subsided. All patients were subsequently treated with aspirin, thalidomide (300 mg daily), and clofazimine (300 mg daily), with or without prednisolone (20 to 30 mg daily). All drugs were gradually reduced, and patients were maintained on clofazimine (100 mg on alternate days) along with dapsone (100 mg daily) and rifampin (1,200 mg monthly).
Stimulants. (i) Autoclaved, armadillo-derived M. leprae (lepromin A), kindly supplied by R. J. W. Rees, NIMR, London, was used in the leukocyte migration inhibition test.
(ii) M. leprae extracted from skin biopsies from bacilliferous LL patients as described earlier (25) were used for the lymphoproliferative and suppressor cell assay. In brief, the tissue was homogenized in glass homogenizers in RPMI 1640 after prior removal of the epidermis. Extracted bacilli were screened for the absence of other contaminating bacteria by culturing on (i) nutrient agar for 72 h and (ii) LowensteinJenson medium for 8 weeks. The bacilli were counted by the standard method described earlier (8) Lymphoproliferation assay. Quadruplicates of 105 PBMC in 100 p.l of medium and 25 p.l of (i) medium, (ii) suboptimal PHA-P, (iii) optimal PHA-P, (iv) integral antigen at 1.25 x 105, (v) integral antigen at 1.25 x 106, (vi) integral antigen at 1.25 x 107, and (vii, viii, and ix) sonicated antigens corresponding to iv, v, and vi were set up in round-bottomed microculture plates (Nunc, Roskilde, Denmark). The cells were incubated at 37°C in 5% CO2 and air. Mitogen and antigen cultures were terminated after 72 and 144 h, respectively. The cells were harvested onto glass fiber discs by a semiautomatic cell harvester (Ilacon, Tonbridge, U.K.) 18 to 20 h after the addition of 0.5 ,uCi of [3H]thymidine (specific activity, 1.80 Ci/mmol; Bhabha Atomic Research Centre, Trombay, India). Radioactivity was counted in a Rackbeta II 1215 scintillation counter (LKB Instruments, Inc., Rockville, Md.). The counts per minute (cpm) ± the standard error of replicate cultures were calculated, and the degree of proliferation (Acpm) was derived as: Acpm = cpm in stimulated cultures -cpm in unstimulated cultures.
Suppressor cell assay. The costimulant assay described earlier (22) from our laboratory was used with the proviso that PHA-P was used as a mitogen instead of concanavalin A (Pharmacia). In brief, quadruplicate cultures were set up. One-hundred-microliter volumes of 105 PBMC per well were cultured with (i) 25 RI of RPMI 1640, (ii) 25 RI of integral or sonicated M. leprae antigen (5 x 106 bacilli per ml), (iii) 25 [lI of antigen followed by 25 pl1 of PHA-P (20 ,ug/ml), (iv) 200 pI/ml 24 M. leprae antigens in leprosy as a whole. Integral and membrane-filtered sonicated bacillary antigens were used to evaluate responses to surface and cytoplasmic antigens, respectively. Three concentrations of the antigens corresponding to suboptimal, optimal, and supraoptimal bacillary numbers were used for both antigens to cover any doserelated differences in the lymphoproliferative responses. Only optimal responses are included in the results.
Nonreactional, stable leprosy. Whereas tuberculoid leprosy patients showed optimal responses to PHA-P and M. leprae antigens (Table 2 ), all LL patients showed a lack of antigeninduced leukocyte migration inhibition (Fig. la) and lymphoproliferative in vitro responses to soluible and integral M. leprae antigens (Fig. lc) . Moreover, the majority of LL patients showed poor mitogen responses (Fig. lb) . In conformity with our earlier observations with concanavalin A as mitogen (22) , stable LL patients showed no or poor inhibition of mitogen responsiveness in the presence of both types of M. leprae antigen (Fig. ld) .
Active ENL. Leukocyte migration inhibition test. Nine patients tested during active ENL and before institution of specific antireaction therapy gave evidence of strong antigen-induced leukocyte mnigration inhibition in response to heat-killed integral M. leprae (Fig. la) . The mean MI for the ENL group (MI = 0.058 ± 0.01) was significantly different (P <0.005) from that of control LL patients who showed the expected unresponsiveness (mean MI = 0.86 ± 0.10). Interestingly, the level of migration inhibition in the ENL group matched the levels attained in responder tuberculoid leprosy individuals (Table 2) . Three patients tested within a week of initiation of antireaction therapy showed abrogation of migration inhibition (mean MI = 0.39 ± 0.10).
Lymphoproliferative responses. We evaluated mitogeninduced lymphoproliferation at both suboptimal (20 ,ug/ml) and optimal (200 p.gIml) concentrations of PHA-P with a view to cover dose-related alterations, if any, in T-cell responsiveness during acute ENL. Some ENL patients showed enhanced mitogen responsiveness compared with the nonreactional group at both concentrations of PHA-P (Fig. lb) . The mean Acpm + the standard error for the ENL activity generated by integral ( (Fig. ic) . Responsiveness to both integral and soluble antigens in the ENL group was significantly higher (P <0.01) compared with the uncomplicated LL group. However, the degree of proliferation observed in ENL patients was relatively lower than that seen in the tuberculoid responder group ( Table 2 ). The mean zAcpm with integral and soluble antigens in the ENL group were 1,331 ± 286 and 2,495 ± 557, respectively.
Suppressor cell activity. Antigen-induced suppressor cell activity was assessed in a costimulant assay as described earlier (22), whereby the effect of integral and sonicated antigens on mitogen responses of the patients were graded. Fig. ld gives individual data for both antigens for both groups of patients. The mean percent suppression in the stable LL group was 10.8 ± 7.1 and 10.78 ± 3.59% with integral and soluble antigens, respectively. ENL patients showed significant enhancement of suppression, the mean percent suppression being 28.9 ± 4.7 and 32.4 ± 5.4% for integral (P <0.01) and sonicated (P <0.05) antigens, respectively. This increase in suppression noted in ENL was only observed when suboptimal PHA-P was used. The degree of suppression induced by the two antigen preparations showed no differences between the stable LL and ENL groups when the optimal PHA-P concentration was used in the assay.
Lymphocyte subsets. T-cell subsets in the PBMC of both groups of patients were characterized by indirect immunofluorescence with monoclonal antibodies OKT3, OKT4, and OKT8. Nine ENL patients showed an increase in OKT8+ cells with a significantly (P <0.05) lower OKT4/OKT8 ratio (0.81 ± 0.1) compared with that observed in patients with uncomplicated LL (1.68 + 0.25) ( Table 3) . B-cell percentages in the PBMC of ENL patients were similar to those of uncomplicated LL individuals (Table 3) .
Delayed-hypersensitivity reaction. All patients with ENL showed absence of erythema and induration 48 h after intradermal injection of soluble armadillo-derived M. leprae antigens (10 Fxg/ml). This lack of responsiveness paralleled the anergy observed in nonreactional LL patients (Table 4) .
Post-ENL status. Of the ENL patients, 7 were tested after subsidence of lesions and termination of reaction-specific therapy. All patients showed a reversal of the T-cell reactivity observed during active ENL (Fig. 2) . The levels of MI, (Fig. 2a) , lymphoproliferative responses (Fig. 2b and c) , and suppressor activity (Fig. 2d) in post-ENL patients were similar to those observed in the control group of patients with uncomplicated LL.
DISCUSSION
The present study provides evidence for the natural emergence of transient T-cell reactivity in hitherto anergic LL patients during the reactional phase of ENL (16) . Significantly, both lymphoproliferative and lymphokine-related in vitro T-cell responses to M. leprae antigens were detectable in many ENL patients. The degree of leukocyte migration inhibition in the acute phase of the reaction was similar to that obtained with cells from responder tuberculoid leprosy patients. Of the 11 ENL individuals, 9 showed significant lymphoproliferative responses in the presence of both solu- (15, 35) . ENL lesions are known to frequently show fragmented bacilli (28) . It is possible that the transient increase in T-cell reactivity may play a role in bacterial killing.
Suppressor T-cell activity was evaluated in leprosy patients in a costimulant assay (22) , whereby the effect of antigens on the mitogenic responses of PBMC was measured. We (20, 22, 23) , as well as others (4, 32, 34) (15, 35) . Some of these differences may be related to the stage of ENL at the time of study, ethnic differences, and methodological variables for the detection of phenotype-positive cells.
The enhanced antigen-induced T-cell reactivity observed in vitro was not reflected in vivo after concomitant intradermal challenge with soluble M. leprae antigens. Lack of skin test reaction was noted both during and after ENL reactions, though the same batch of antigen showed positive reactions in tuberculoid leprosy patients (mean induration = 21.75 mm). It is possible that (i) there is a time lag before the changes observed in circulation are reflected in tissues, (ii) different antigenic determinants are involved in in vivo and in vitro responses, and (iii) more than one type of delayed hypersensitivity exists in leprosy. This persistent lack of dermal reactivity is particularly intriguing, since significant increases in numbers of T4+ T cells have been detected in ENL lesions by us (17) and others (13) , thereby ruling out any major inherent defect in the traffic of T cells into leprosy lesions.
The presence of antigen-reactive T cells in anergic LL patients has been recently shown by us (21) and others (9, 24) . 
